Elaine Vickers, PhD, from Science Communicated Ltd., Manchester, UK, describes the exciting aspect of immuotherapeutic research. However, survival responses from immunotherapies are inadequete and Dr. Vickers discusses the approaches to improving the survival rates seen in patients from current immunotherapies. Speaking at the 2018 National Cancer Research Institute (NCRI) Cancer Conference, held in Glasgow, UK, Dr Vickers also focuses on future potential avenues for combination therapies.